Baker Avenue Asset Management, LP - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Avenue Asset Management, LP ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$70,000
-15.7%
92,878
+9.4%
0.01%
-14.3%
Q2 2019$83,000
-30.8%
84,8780.0%0.01%
-30.0%
Q1 2019$120,00084,8780.01%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders